TileBio
TileBio is an AI pathology company developing self-learning foundation models that create a universal visual language of tissue without human input, transforming clinical diagnostics, biomarker discovery, and target development. Their proprietary technology converts histopathology images into an AI-learned visual language, enabling advanced interpretation of pathological data. This self-supervised method scales across millions of unlabelled patient samples, detecting patterns beyond human perception to improve diagnostic accuracy and accelerate biomedical research. The company's mission is to make pathology knowledge accessible for faster, more accurate diagnostics and accelerate the discovery of new biomarkers and therapies. They leverage state-of-the-art large language model techniques and proprietary LLMs for this purpose. TileBio's impact lies in enabling earlier disease detection, uncovering novel biomarkers, and optimizing drug discovery and clinical trial design.
TileBio
TileBio is an AI pathology company developing self-learning foundation models that create a universal visual language of tissue without human input, transforming clinical diagnostics, biomarker discovery, and target development. Their proprietary technology converts histopathology images into an AI-learned visual language, enabling advanced interpretation of pathological data. This self-supervised method scales across millions of unlabelled patient samples, detecting patterns beyond human perception to improve diagnostic accuracy and accelerate biomedical research. The company's mission is to make pathology knowledge accessible for faster, more accurate diagnostics and accelerate the discovery of new biomarkers and therapies. They leverage state-of-the-art large language model techniques and proprietary LLMs for this purpose. TileBio's impact lies in enabling earlier disease detection, uncovering novel biomarkers, and optimizing drug discovery and clinical trial design.